[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-05-13-20":3},{"date":4,"filings":5,"has_more":623,"limit":624,"page":625,"total_count":626},"2026-05-13",[6,14,21,28,35,42,49,57,64,70,77,84,91,98,105,112,119,124,129,135,140,145,152,159,165,171,178,184,189,196,201,206,213,219,226,233,238,243,249,254,261,266,272,279,284,291,298,303,309,315,320,325,331,338,344,350,357,364,371,378,383,390,395,402,407,412,419,425,431,437,442,449,456,463,469,474,479,484,490,495,500,505,510,517,523,530,535,542,549,554,561,566,573,578,584,591,598,605,610,616],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"MTAR Technologies Ltd","2026-05-13T14:11:42.558000","BSE","Q4 & FY26 Earnings Call Audio Recording Now Available","6a043976ecaa861d94924d17","MTARTECH","*   The audio recording for the Q4 & FY26 Earnings Conference Call, held on May 13, 2026, is now available on the company's website.\n*   This filing is a procedural intimation to the stock exchanges as required by SEBI regulations.\n*   Please note: This document does not contain financial results. Investors must listen to the audio recording for details on performance and management outlook.",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":18,"stock_code":19,"summary_text":20},"El Forge Ltd","2026-05-13T14:11:42.557000","Board Meeting Scheduled for May 20 to Approve Financial Results","6a043972f43b112c8d923689","531144","• The Board of Directors will meet on Wednesday, May 20, 2026.\n• The primary agenda is to consider and approve the Audited Financial Results for the quarter and year ended March 31, 2026.\n• The trading window for designated persons has been closed from April 01, 2026, and will reopen 48 hours after the results are made public.",{"company_name":22,"filing_date":23,"filing_source":9,"headline":24,"id":25,"stock_code":26,"summary_text":27},"Flora Corporation Ltd","2026-05-13T14:11:42.397000","FY26 Profit Soars 198% Despite Revenue Dip, Dividend Proposed","6a04399258d87443453a30c2","540267","*   **FY26 Financials:** Revenue from Operations declined 42.85% YoY to ₹8,452.15 Lakhs. However, Profit After Tax (PAT) surged 198.10% YoY to ₹31.42 Lakhs, driven by significant cost-cutting.\n*   **Dividend:** The Board of Directors has proposed a final dividend for the financial year 2026, subject to shareholder approval at the AGM.\n*   **Audit Opinion:** The company received an unmodified (\"clean\") audit opinion, indicating the financial statements present a true and fair view.\n*   **Key Disclosure:** The company is exempt from mandatory disclosure of related party transactions due to its size (Net Worth \u003C ₹25 Cr), which reduces investor transparency.\n*   **Minor Red Flag:** Auditors noted delays in the company's remittance of Tax Deducted at Source (TDS), pointing to a minor compliance issue.",{"company_name":29,"filing_date":30,"filing_source":9,"headline":31,"id":32,"stock_code":33,"summary_text":34},"Rita Finance and Leasing Ltd","2026-05-13T14:11:42.343000","Rita Finance Allots 60 Lakh Warrants to Raise up to ₹12 Crore","6a043981ec7f5de862c59856","543256","*   The Board has approved the preferential allotment of 60,00,000 convertible warrants to 18 entities, all in the \"Non-Promoter Category.\"\n*   This action will raise an immediate ₹3 crore, with a total potential capital infusion of up to ₹12 crore upon full conversion.\n*   Each warrant is priced at ₹20 and can be converted into one equity share within 18 months, which will significantly alter the company's shareholding pattern.\n*   The move signals significant potential equity dilution for existing shareholders, with several new entities poised to become substantial shareholders.",{"company_name":36,"filing_date":37,"filing_source":9,"headline":38,"id":39,"stock_code":40,"summary_text":41},"Blue Coast Hotels Ltd","2026-05-13T14:11:42.327000","Promoter Group Increases Stake via Preferential Share Allotment","6a04397c5236ec99893a1c03","BLUECOAST","*   The Board has approved the allotment of 24,87,100 new equity shares by converting Compulsorily Convertible Preference Shares (CCPS).\n*   The entire allotment was made exclusively to 11 entities belonging to the \"Promoter & Promoter Group,\" significantly increasing their consolidated holding and voting power.\n*   This action results in equity dilution for existing public shareholders.\n*   Following the allotment, the company's Paid-up Equity Share Capital has increased to ₹19,67,95,570.\n*   The Board also approved the re-appointment of M\u002Fs Sidharth K Agarwal & Co. as the Internal Auditor for the financial year 2026-27.",{"company_name":43,"filing_date":44,"filing_source":9,"headline":45,"id":46,"stock_code":47,"summary_text":48},"Smartlink Holdings Ltd","2026-05-13T14:11:42.298000","FY26 Results: Profit Doubles, ₹2 Dividend Recommended & Key Leadership Changes","6a043987bf8f716f13ffd01a","SMARTLINK","- \u003Cb>Strong Consolidated Growth:\u003C\u002Fb> FY26 Profit After Tax (PAT) nearly doubled to ₹1,314.55 Lakhs (+99% YoY), with revenue up 25.6% to ₹26,934.75 Lakhs.\n- \u003Cb>Dividend Declared:\u003C\u002Fb> The Board has recommended a final dividend of ₹2.00 per equity share, subject to shareholder approval.\n- \u003Cb>Key Red Flag:\u003C\u002Fb> Standalone profit was artificially inflated by a one-time, non-cash reversal of a ₹1,288.36 Lakh impairment. Underlying operational profit was minimal.\n- \u003Cb>Governance Updates:\u003C\u002Fb> The Board approved the appointment of the Chairman's daughter, Ms. Arati Naik, as an Executive Director and proposed a change in Statutory Auditors to M\u002Fs MSKA & Associates LLP.",{"company_name":50,"filing_date":51,"filing_source":52,"headline":53,"id":54,"stock_code":55,"summary_text":56},"Service Care Limited","2026-05-13T14:11:39.698000","NSE","Affirms Full Compliance with SEBI Insider Trading Regulations","6a04396fabd16353d2ffdf68","SERVICE","*   Submitted its annual Compliance Certificate for the Structured Digital Database (SDD) for the financial year ended March 31, 2026.\n*   An external Practising Company Secretary certified that the company is in full compliance with SEBI's regulations for preventing insider trading.\n*   The audit found \"no non-compliance\" and confirmed all 3 required sensitive information (UPSI) events for the year were successfully recorded.\n*   This filing indicates a strong governance and compliance culture, a positive signal for shareholders.",{"company_name":58,"filing_date":59,"filing_source":52,"headline":60,"id":61,"stock_code":62,"summary_text":63},"Suven Life Sciences Limited","2026-05-13T14:11:39.647000","Approves Grant of 1.33 Lakh Stock Options","6a04396fa157653c663a406e","SUVEN","*   The company has granted **1,33,200 Employee Stock Options (ESOPs)** under its \"SLSL ESOP 2020\" scheme.\n*   The exercise price is set at **₹ 55\u002F- per option**.\n*   Vesting will occur in three tranches, starting one year from the grant date: 40% on May 13, 2027, 30% on May 13, 2028, and the final 30% on May 13, 2029.\n*   This action serves as a long-term employee incentive and may result in potential equity dilution for existing shareholders upon exercise.",{"company_name":65,"filing_date":66,"filing_source":52,"headline":67,"id":68,"stock_code":12,"summary_text":69},"Mtar Technologies Limited","2026-05-13T14:11:39.633000","Q4 FY26 Earnings Call Audio Now Available","6a0439690c6b4fb98a925d38","*   The company has informed stock exchanges that the audio recording for its Q4 FY 2025-26 earnings conference call is now public.\n*   This disclosure is in compliance with SEBI (LODR) Regulations, 2015, enhancing transparency for investors.\n*   The audio recording can be accessed on the company's corporate website via the link provided in the filing.\n*   This filing is a procedural notification; the actual discussion on performance and outlook is contained within the audio recording itself.",{"company_name":71,"filing_date":72,"filing_source":9,"headline":73,"id":74,"stock_code":75,"summary_text":76},"Kirloskar Brothers Ltd","2026-05-13T14:06:41.923000","FY26 Results: Profit Dips on One-Time Charge, Recommends ₹7 Dividend","6a04389aec7f5de862c59850","KIRLOSBROS","*   The Board has recommended a final dividend of \u003Cb>₹7.00 per share\u003C\u002Fb> for the financial year 2025-26.\n*   Consolidated revenue from operations grew marginally by 1.02% YoY to ₹45,380 million.\n*   Consolidated Profit After Tax (PAT) declined by 10.46% YoY to ₹3,612 million.\n*   The profit decline was primarily driven by a one-time exceptional charge of \u003Cb>₹417 million\u003C\u002Fb> (Consolidated) due to new labor regulations.\n*   Basic Earnings Per Share (EPS) for the year stood at \u003Cb>₹47.05\u003C\u002Fb>, down from ₹52.29 in the previous year.",{"company_name":78,"filing_date":79,"filing_source":9,"headline":80,"id":81,"stock_code":82,"summary_text":83},"KIFS Financial Services Ltd","2026-05-13T14:06:41.883000","Board Meeting to Discuss FY26 Results & Final Dividend","6a04387658d87443453a30bc","535566","*   A Board of Directors meeting is scheduled for May 20, 2026.\n*   The agenda includes approving the audited financial results for the year ended March 31, 2026.\n*   The Board will also consider recommending a final dividend for the financial year 2025-26.\n*   The trading window for insiders is closed from April 1, 2026, until 48 hours after the results are declared.",{"company_name":85,"filing_date":86,"filing_source":9,"headline":87,"id":88,"stock_code":89,"summary_text":90},"BLS E-Services Ltd","2026-05-13T14:06:41.783000","Board Meeting Set for May 18 to Discuss FY26 Results & Dividend","6a043873890e096a6fc5bf72","BLSE","*   A meeting of the Board of Directors is scheduled for Monday, May 18, 2026.\n*   The agenda includes approving the audited financial results for the quarter and year ended March 31, 2026.\n*   The Board will also consider declaring a final dividend for the financial year 2025-26.\n*   The trading window for insiders has been closed since April 1, 2026, and will reopen 48 hours after the results are announced.",{"company_name":92,"filing_date":93,"filing_source":9,"headline":94,"id":95,"stock_code":96,"summary_text":97},"Goel Construction Company Ltd","2026-05-13T14:06:41.776000","Board Reappoints Cost and Internal Auditors for FY 2026-27","6a043873f35e30561cffb75c","544504","*   The Board of Directors has approved the reappointment of the company's Cost Auditor and Internal Auditor for the financial year 2026-27 (from April 1, 2026, to March 31, 2027).\n*   \u003Cb>Cost Auditor:\u003C\u002Fb> M\u002Fs Deepak Mittal & Co., Cost Accountants, have been reappointed.\n*   \u003Cb>Internal Auditor:\u003C\u002Fb> M\u002Fs R.K. Akar and Co., Chartered Accountants, have been reappointed.\n*   This is a routine governance procedure to ensure continuity in financial oversight, internal controls, and regulatory compliance.",{"company_name":99,"filing_date":100,"filing_source":9,"headline":101,"id":102,"stock_code":103,"summary_text":104},"Sarla Performance Fibers Ltd","2026-05-13T14:06:41.545000","Announces ₹44 Crore Share Buyback at a Premium","6a0438acc9cbead9b3c5ae50","SARLAPOLY","*   The company will buy back up to 40 lakh shares (4.79% of total) at a price of **₹110 per share**.\n*   The total buyback size is up to **₹44 Crore**, representing a premium of ~30% over the recent 3-month average price.\n*   Crucially, the **Promoter Group (holding 57.11%) will NOT participate**, which is expected to significantly increase the acceptance ratio for public shareholders.\n*   The Record Date to determine eligibility for the buyback is **May 15, 2026**.\n*   \u003Cb>RED FLAG:\u003C\u002Fb> The company's FY26 audited financials have a **qualified opinion** from auditors regarding a potential unresolved loss of ₹7,713.26 lakhs in a subsidiary.",{"company_name":106,"filing_date":107,"filing_source":9,"headline":108,"id":109,"stock_code":110,"summary_text":111},"Manorama Industries Ltd","2026-05-13T14:06:41.508000","Posts Stellar FY26 Results with Profit More Than Doubling","6a04387abf8f716f13ffd014","MANORAMA","*   \u003Cb>Exceptional Annual Growth:\u003C\u002Fb> The company reported exceptional performance for the financial year ended March 31, 2026.\n*   \u003Cb>Net Profit Surge:\u003C\u002Fb> Net Profit After Tax (PAT) for FY26 more than doubled, surging by **104.9%** year-over-year to ₹22,491.80 Lakhs.\n*   \u003Cb>Strong Revenue Growth:\u003C\u002Fb> Total Income from Operations grew significantly by **73.9%** year-over-year to ₹137,709.20 Lakhs.\n*   \u003Cb>Enhanced Shareholder Value:\u003C\u002Fb> Basic Earnings Per Share (EPS) jumped by **104.5%** to ₹37.67 from ₹18.42 in the previous year.\n*   \u003Cb>Quarterly Performance:\u003C\u002Fb> For Q4 FY26, Net Profit grew by 31.0% YoY to ₹5,245.89 Lakhs.",{"company_name":113,"filing_date":114,"filing_source":9,"headline":115,"id":116,"stock_code":117,"summary_text":118},"Pyramid Technoplast Ltd","2026-05-13T14:06:41.392000","[FY26 Revenue Up 15%, But Debt & Margin Pressures Rise]","6a0438645236ec99893a1bf8","PYRAMID","*   **Strong Top-Line Growth:** FY26 revenue grew 15.2% YoY to ₹681 Cr, driven by strong volume growth. The Intermediate Bulk Containers (IBC) segment was the top performer, with revenue surging 24.2%.\n*   **Profitability Squeezed:** Despite revenue growth, PAT margin compressed to 4.2% from 4.5% in FY25. This was caused by a sharp rise in interest (up 179.5%) and depreciation costs from new investments.\n*   **Weakening Balance Sheet:** Net Debt to Equity ratio increased significantly from 0.0x to 0.6x in FY26 to fund capex. The Interest Coverage Ratio has sharply declined from 18.1x to 6.2x.\n*   **New Projects Operational:** The new solar and recycling plants are now live. The solar plant is expected to save over ₹15 Cr annually. However, the recycling plant posted a small initial loss and is awaiting a key regulatory license.\n*   **FY27 Outlook:** Management has guided for ~15% revenue growth with an EBITDA margin of 11%-12% for the upcoming year.",{"company_name":71,"filing_date":120,"filing_source":9,"headline":121,"id":122,"stock_code":75,"summary_text":123},"2026-05-13T14:06:41.376000","FY26 Results: Profit Dips 10% on Regulatory Hit, Declares ₹7 Dividend","6a043879f43b112c8d923683","*   **FY26 Consolidated Revenue:** ₹45,380 Mn, up 1.02% YoY.\n*   **FY26 Consolidated PAT:** ₹3,735 Mn, down 10.04% YoY, with EPS falling to ₹47.05.\n*   **Dividend Declared:** The Board has recommended a final dividend of ₹7.00 per share (350%).\n*   **Profitability Impact:** A significant one-time exceptional charge of ₹417 Mn was booked due to the implementation of new labour laws, impacting profits.\n*   **Strategic Tax Benefit:** The merger of a subsidiary allowed the company to utilize ₹1,261 Mn in brought-forward losses, providing a substantial tax benefit for the year.",{"company_name":43,"filing_date":125,"filing_source":9,"headline":126,"id":127,"stock_code":47,"summary_text":128},"2026-05-13T14:06:40.895000","FY26 Results: Profit Doubles, Board Declares ₹2 Dividend","6a043853ec7f5de862c5984e","*   \u003Cb>Stellar Financials:\u003C\u002Fb> Consolidated Profit After Tax (PAT) nearly doubled to ₹1,314.55 Lakhs (+99% YoY). Standalone PAT surged 421% to ₹1,321.99 Lakhs.\n*   \u003Cb>Red Flag - One-Time Gain:\u003C\u002Fb> The standalone profit was heavily inflated by a one-time, non-operating income of ₹1,288.36 Lakhs from a reversal of impairment.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a final dividend of ₹2.00 per share (100% of face value), subject to shareholder approval.\n*   \u003Cb>Auditor Change:\u003C\u002Fb> The current Statutory Auditors expressed \"unwillingness to continue.\" The Board has recommended appointing MSKA & Associates LLP as the new auditors.\n*   \u003Cb>Board Appointment:\u003C\u002Fb> Approved the appointment of Ms. Arati Naik (daughter of the Executive Chairman) as an Executive Director.",{"company_name":130,"filing_date":131,"filing_source":9,"headline":132,"id":133,"stock_code":62,"summary_text":134},"Suven Life Sciences Ltd","2026-05-13T14:06:40.824000","Approves Grant of 1,33,200 Employee Stock Options","6a043849f35e30561cffb75a","*   The Nomination & Remuneration Committee has approved the grant of **1,33,200 Employee Stock Options (ESOPs)** to eligible employees.\n*   The options have an **exercise price of ₹ 55 per share**.\n*   Vesting will occur in three tranches, starting one year from the grant date, with the first tranche vesting on **May 13, 2027**.\n*   The grant is part of the \"SLSL ESOP 2020\" scheme and may lead to **future equity dilution** for shareholders upon exercise.",{"company_name":71,"filing_date":136,"filing_source":9,"headline":137,"id":138,"stock_code":75,"summary_text":139},"2026-05-13T14:06:40.793000","FY26 Results: Net Profit Dips 10%, Board Recommends ₹7 Dividend","6a043883ecaa861d94924d10","*   Net Profit for FY26 fell 10% to ₹3,735 Mn, primarily due to a one-time exceptional charge of ₹389 Mn related to new labour laws.\n*   The Board has recommended a final dividend of ₹7.00 per equity share for the financial year.\n*   The profit drop was partially offset by a significant one-off tax benefit from utilizing losses of a merged subsidiary.\n*   Revenue from operations grew a modest 1.02%, driven by international business which masked a decline in domestic revenue.",{"company_name":92,"filing_date":141,"filing_source":9,"headline":142,"id":143,"stock_code":96,"summary_text":144},"2026-05-13T14:06:40.749000","Key Auditor Appointments Confirmed for FY 2026-27","6a04383f58d87443453a30b7","*   The Board of Directors has approved the reappointment of the Cost Auditor and Internal Auditor for the financial year 2026-27 (April 1, 2026, to March 31, 2027).\n*   **Cost Auditor**: M\u002Fs Deepak Mittal & Co., Cost Accountants.\n*   **Internal Auditor**: M\u002Fs R.K. Akar and Co., Chartered Accountants.\n*   The reappointments, recommended by the Audit Committee, ensure continuity in financial oversight and regulatory compliance.\n*   The company confirmed no relationships exist between its directors and the audit firms, aligning with good corporate governance practices.",{"company_name":146,"filing_date":147,"filing_source":52,"headline":148,"id":149,"stock_code":150,"summary_text":151},"Yatharth Hospital & Trauma Care Services Limited","2026-05-13T14:06:40.628000","Yatharth Hospital Announces Major Expansion in Gurugram","6a043848c9cbead9b3c5ae4e","YATHARTH","*   The company is acquiring an under-construction, 250-bed super-specialty hospital in Gurugram, marking its entry into this key market.\n*   The total project cost is estimated at ~₹200 crores, which includes ~₹100 crores for the acquisition and ~₹100 crores for completion and equipment.\n*   This strategic move is aimed at catering to the growing demand for high-end healthcare services in the Delhi NCR region.\n*   The acquisition will increase the company's total announced bed capacity to approximately 3,250 beds.",{"company_name":153,"filing_date":154,"filing_source":52,"headline":155,"id":156,"stock_code":157,"summary_text":158},"Onesource Specialty Pharma Limited","2026-05-13T14:06:40.571000","Board Appoints New Statutory Auditor","6a04383cbf8f716f13ffd00e","ONESOURCE","*   The Board of Directors has approved the appointment of **M\u002Fs. B S R & Co. LLP, Chartered Accountants**, as the new Statutory Auditor.\n*   The appointment is for a term of **five consecutive years**, commencing from the conclusion of the 60th Annual General Meeting (AGM).\n*   This is subject to shareholder approval at the 60th AGM, with a proposed effective date of **23 September 2026**.\n*   The appointment of a large, reputable firm is a significant governance event, viewed as a move to enhance the credibility and transparency of financial reporting.",{"company_name":160,"filing_date":161,"filing_source":52,"headline":162,"id":163,"stock_code":75,"summary_text":164},"Kirloskar Brothers Limited","2026-05-13T14:06:40.403000","FY26 Results: Declares ₹7 Dividend Despite Profit Dip","6a0438840c6b4fb98a925d32","*   The Board has recommended a final dividend of **₹7.00 per share** (350%) for the financial year 2025-26.\n*   Consolidated Profit After Tax (PAT) declined by 9.37% YoY to ₹3,735 million, while Revenue from Operations grew marginally by 1.02% to ₹45,380 million.\n*   Profitability was impacted by a one-time exceptional charge of **₹417 million** (consolidated) related to the implementation of new Labour Codes.\n*   The company utilized **₹1,261 million in tax losses** from a subsidiary merger, which positively impacted the year's tax expense.\n*   The 106th Annual General Meeting (AGM) is scheduled for **31 July 2026**.",{"company_name":166,"filing_date":167,"filing_source":52,"headline":168,"id":169,"stock_code":47,"summary_text":170},"Smartlink Holdings Limited","2026-05-13T14:06:40.337000","FY26 Results: Profit Jumps & Dividend Declared, But Auditor Change Raises Red Flag","6a043861a157653c663a405f","*   Consolidated Profit After Tax (PAT) grew 99% YoY to ₹1,314.55 Lakhs for FY26, while revenue increased by 23.6%.\n*   The Board has recommended a final dividend of ₹2.00 per equity share.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The current statutory auditors have conveyed their \"unwillingness to continue,\" prompting a change in auditors, a significant governance event.\n*   \u003Cb>Red Flag:\u003C\u002Fb> Standalone profit was artificially inflated by a one-time, non-cash impairment reversal of ₹1,288.36 Lakhs, masking weak core operational profitability.\n*   The Board approved the appointment of the Chairman's daughter, Ms. Arati Naik, as a Wholetime Director for a five-year term.",{"company_name":172,"filing_date":173,"filing_source":52,"headline":174,"id":175,"stock_code":176,"summary_text":177},"HDFC Bank Limited","2026-05-13T14:06:40.287000","HDFC Bank Completes ₹1,035 Crore Bond Redemption","6a043842890e096a6fc5bf6e","HDFCBANK","*   HDFC Bank has confirmed the timely payment of final interest and principal for its Non-Convertible Debentures (ISIN: INE040A08500).\n*   The bank successfully redeemed the full principal amount of \u003Cb>₹1,035 Crores\u003C\u002Fb> upon maturity.\n*   A final interest payment of ₹86.42 Crores was also made.\n*   All payments were completed on the due date, May 13, 2026, leaving no outstanding amount for this bond series.\n*   This action highlights the bank's strong financial discipline and ability to meet its debt obligations.",{"company_name":179,"filing_date":180,"filing_source":52,"headline":181,"id":182,"stock_code":110,"summary_text":183},"Manorama Industries Limited","2026-05-13T14:06:40.250000","FY26 Profit Doubles, But Q4 Sees Sharp Sequential Decline","6a043855abd16353d2ffdf4a","*   \u003Cb>Record Full-Year Performance (FY26):\u003C\u002Fb> Net Profit After Tax (PAT) surged by 104.86% to ₹22,491.80 Lakhs, while Total Income grew 73.91% year-over-year.\n*   \u003Cb>Q4 Profit Concern:\u003C\u002Fb> Despite strong annual results, Q4 Net Profit fell sharply by 27.42% compared to the previous quarter (QoQ), indicating significant margin pressure.\n*   \u003Cb>EPS Soars:\u003C\u002Fb> Full-year Diluted EPS for FY26 more than doubled to ₹37.66, a 105.23% increase from ₹18.35 in FY25.",{"company_name":71,"filing_date":185,"filing_source":9,"headline":186,"id":187,"stock_code":75,"summary_text":188},"2026-05-13T14:01:42.574000","FY26 Results: Profit Dips on One-Time Charge, but Dividend Strong at ₹7\u002FShare","6a0437465236ec99893a1bf3","*   **Financials:** Consolidated Profit After Tax (PAT) for FY26 fell 10% YoY to ₹3,735 Million, while revenue remained flat (+1.02%).\n*   **Key Driver:** The profit decline was primarily due to a one-time exceptional charge of ₹417 Million related to the implementation of new Labour Codes.\n*   **Dividend:** The Board has recommended a final dividend of ₹7.00 per share (350%) for the financial year 2025-26.\n*   **Auditor's Opinion:** The company received an unmodified (clean) opinion from its statutory auditors on the financial statements.\n*   **AGM Date:** The 106th Annual General Meeting (AGM) will be held on July 31, 2026.",{"company_name":190,"filing_date":191,"filing_source":9,"headline":192,"id":193,"stock_code":194,"summary_text":195},"3P Land Holdings Ltd","2026-05-13T14:01:42.394000","Special Window for Physical Share Transfers","6a043724f35e30561cffb755","3PLAND","*   The company has announced a special one-year window for shareholders to re-submit physical share transfer requests that were rejected or returned before 01 April 2019.\n*   This special window is open from **05 February 2026 to 04 February 2027**.\n*   This is a significant opportunity for affected shareholders to resolve pending transfers and formalize their ownership.\n*   **Important**: All shares re-lodged for transfer during this period will be issued **only in dematerialized (demat) form**.\n*   This action is a compliance measure mandated by a SEBI circular and is considered a positive, shareholder-friendly initiative.",{"company_name":71,"filing_date":197,"filing_source":9,"headline":198,"id":199,"stock_code":75,"summary_text":200},"2026-05-13T14:01:42.253000","Rama Kirloskar Re-appointed as Joint MD; PwC Named Internal Auditor","6a043729ec7f5de862c59847","*   The Board has approved the re-appointment of Ms. Rama Kirloskar as Joint Managing Director for a 5-year term, subject to shareholder approval at the upcoming AGM.\n*   This is a material related party transaction that reinforces the promoter family's control, a key governance factor for investors to consider.\n*   Ms. Kirloskar's past success, including the turnaround of the KEPL joint venture, is cited as a key credential for her re-appointment.\n*   PricewaterhouseCoopers (PwC) has been appointed as a co-sourced Internal Auditor, a move that may strengthen internal controls and governance.",{"company_name":130,"filing_date":202,"filing_source":9,"headline":203,"id":204,"stock_code":62,"summary_text":205},"2026-05-13T14:01:42.240000","Posts Wider FY26 Loss on R&D Surge; Key Drug Trial Nears Completion","6a043735f43b112c8d92367f","*   **Financials:** Net loss for FY26 widened by 72% to ₹27,634 Lakhs, driven by a 72% surge in R&D expenses to ₹24,819 Lakhs.\n*   **Pipeline Update:** The global Phase 3 trial for its lead drug, SUVN-502 (Masupirdine), is 76% enrolled, with completion expected by the end of calendar year 2026.\n*   **Strong Cash Position:** The company holds a substantial cash balance with ₹50,364 Lakhs in unutilized funds from a recent preferential issue, providing a significant financial runway.\n*   **Governance:** The company received a waiver of fines from BSE for past non-compliance and is awaiting a similar outcome from NSE. The Board has advised for \"greater diligence\" in the future.",{"company_name":207,"filing_date":208,"filing_source":9,"headline":209,"id":210,"stock_code":211,"summary_text":212},"Punjab Communications Ltd","2026-05-13T14:01:42.128000","Board to Meet on May 20 to Approve Q4 & Annual Financials","6a043720ecaa861d94924d05","500346","• A Board Meeting is scheduled for \u003Cb>May 20, 2026, at 11:00 AM\u003C\u002Fb>.\n• The main agenda is to approve the audited financial results for the quarter and year ended \u003Cb>March 31, 2026\u003C\u002Fb>.\n• The Trading Window will remain closed for insiders until \u003Cb>May 22, 2026\u003C\u002Fb>.",{"company_name":214,"filing_date":215,"filing_source":9,"headline":216,"id":217,"stock_code":150,"summary_text":218},"Yatharth Hospital & Trauma Care Services Ltd","2026-05-13T14:01:42.052000","Announces INR 200 Crore Investment for New Gurugram Hospital","6a04372658d87443453a30b1","*   Announced the acquisition of an under-construction, 250-bed super-specialty hospital in Gurugram.\n*   The total planned investment for the project is approximately INR 200 crores, covering the acquisition cost (~INR 100 cr) and project completion (~INR 100 cr).\n*   This acquisition marks the company's strategic entry into the high-growth Gurugram healthcare market, part of the Delhi NCR region.\n*   Post-acquisition, the company's network will expand to 9 hospitals with a total capacity of over 2,800 beds.",{"company_name":220,"filing_date":221,"filing_source":52,"headline":222,"id":223,"stock_code":224,"summary_text":225},"Muthoot Capital Services Limited","2026-05-13T14:01:40.157000","Muthoot Capital's FY26: Diversification Drives Growth Amidst Rising Costs & NPAs","6a043751c9cbead9b3c5ae49","MUTHOOTCAP","*   **AUM Growth:** MCSL's core own-book AUM grew 29% to ₹2,758 Crores, offsetting a planned 37% reduction in the co-lending portfolio.\n*   **New Verticals:** Explosive growth in new segments, with Commercial Vehicle AUM up 292% and Used Car AUM up 80%, validating the company's diversification strategy.\n*   **Asset Quality:** Gross NPA is high at 6.96%, significantly impacted by a one-off corporate loan default of ₹15.51 Crores. The core retail GNPA stands at 5.64%.\n*   **Profitability Pressure:** The Cost-to-Income ratio is at a very high 85% due to strategic investments in technology and new business verticals.\n*   **Future Plans:** The company targets an AUM of close to ₹4,500 Crores for FY27 and is planning to raise ~₹400 Crores in equity in the next 2-3 months.\n*   **No Dividend:** No dividend was declared for FY26, with management prioritizing capital reinvestment for growth.",{"company_name":227,"filing_date":228,"filing_source":52,"headline":229,"id":230,"stock_code":231,"summary_text":232},"Jet Freight Logistics Limited","2026-05-13T14:01:40.054000","Posts 81% Jump in Net Profit for FY26","6a04373b0c6b4fb98a925d2c","JETFREIGHT","- **Stunning Profit Growth:** Net Profit (PAT) for the full year (FY26) surged by 81.5% to ₹680.86 Lakhs, even as revenue remained stable.\n- **Efficiency Gains:** The profit jump was driven by strong cost management and operational efficiency, resulting in an 83.3% increase in Profit Before Tax (PBT).\n- **Shareholder Value:** Basic Earnings Per Share (EPS) increased by 83.75% to ₹1.47 for the year, up from ₹0.80 in FY25.\n- **Governance Update:** The company received an unmodified audit opinion and appointed M\u002Fs. Daya & Associates as the new Internal Auditors for FY 2026-27.",{"company_name":160,"filing_date":234,"filing_source":52,"headline":235,"id":236,"stock_code":75,"summary_text":237},"2026-05-13T14:01:40.050000","Leadership Continuity & Governance Strengthened","6a043720abd16353d2ffdf37","*   The Board approved the re-appointment of Ms. Rama Kirloskar as Joint Managing Director for a 5-year term, subject to shareholder approval.\n*   Ms. Kirloskar is noted for her successful turnaround of the Kirloskar Ebara Pumps Limited (KEPL) joint venture into a debt-free company.\n*   PricewaterhouseCoopers (PwC) has been appointed as the co-sourced Internal Auditor for FY 2026-27, a move seen as strengthening internal controls.\n*   The re-appointment continues the significant involvement of the promoter family in key executive roles.",{"company_name":153,"filing_date":239,"filing_source":52,"headline":240,"id":241,"stock_code":157,"summary_text":242},"2026-05-13T14:01:40.043000","[Allots New Equity Shares Under ESOP]","6a043719a157653c663a4052","*   Allotted 3,150 new equity shares on May 13, 2026, following the exercise of options under the company's Employee Stock Option Plan (ESOP).\n*   This action increases the total issued share capital from 114,642,651 to 114,645,801 shares.\n*   The filing was made in compliance with SEBI's Share Based Employee Benefits regulations.",{"company_name":244,"filing_date":245,"filing_source":52,"headline":246,"id":247,"stock_code":117,"summary_text":248},"Pyramid Technoplast Limited","2026-05-13T14:01:39.937000","FY26 Sees Strong Revenue Growth, But Balance Sheet Shows Strain","6a043739890e096a6fc5bf67","*   FY26 revenue grew 15% YoY to ₹681 Cr, driven by a 20% volume increase. The Intermediate Bulk Container (IBC) segment was the top performer with 24% revenue growth.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The balance sheet has deteriorated significantly due to heavy capex. The Interest Coverage Ratio plummeted from 14.4x in FY25 to 6.2x in FY26, and Net Debt\u002FEquity rose to 0.64x.\n*   The new recycling plant is currently loss-making and awaits a critical license (expected July 2026), while a new solar plant is expected to save over ₹15 Cr in annual power costs.\n*   \u003Cb>FY27 Outlook:\u003C\u002Fb> Management guides for ~15% revenue growth with improved EBITDA margins of 11-12%, driven by cost savings and operational efficiencies from new plants.",{"company_name":113,"filing_date":250,"filing_source":9,"headline":251,"id":252,"stock_code":117,"summary_text":253},"2026-05-13T13:56:42.937000","FY26 Results: Revenue Grows, But Debt & Negative Cash Flow Raise Concerns","6a04363ebf8f716f13ffd001","*   \u003Cb>Revenue Growth:\u003C\u002Fb> Revenue from operations grew 15.1% YoY to ₹68,090.84 Lakhs, though Net Profit growth was a slower 8.0%, indicating margin pressure.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board recommended a final dividend of Re. 0.50 per share for FY26, subject to shareholder approval.\n*   \u003Cb>RED FLAG - Soaring Debt:\u003C\u002Fb> Total borrowings surged by a massive 237% YoY to fund expansion, causing finance costs to jump 179% and significantly increasing financial risk.\n*   \u003Cb>RED FLAG - Negative Cash Flow:\u003C\u002Fb> Cash Flow from Operations turned sharply negative to (₹4,137.28) Lakhs, a major concern indicating profits are not converting to cash.\n*   \u003Cb>Aggressive Expansion:\u003C\u002Fb> The company is in a major capex cycle, doubling its fixed assets. This explains the high debt and presents both a growth opportunity and significant execution risk.",{"company_name":255,"filing_date":256,"filing_source":9,"headline":257,"id":258,"stock_code":259,"summary_text":260},"Ugar Sugar Works Ltd","2026-05-13T13:56:42.705000","Receives Clean Audit Report for FY26","6a04361658d87443453a30a8","530363","• The company has received an **unmodified (clean) audit opinion** from its Statutory Auditors, Kirtane & Pandit LLP.\n• This opinion is for the Audited Standalone Financial Results for the quarter and year ended March 31, 2026.\n• A clean audit report is a positive indicator, suggesting the company's financial statements are fair, accurate, and transparent, with no material misstatements found by the auditors.",{"company_name":36,"filing_date":262,"filing_source":9,"headline":263,"id":264,"stock_code":40,"summary_text":265},"2026-05-13T13:56:42.477000","Board Approves Allotment of 2.48 Million Shares to Promoter Group","6a04361fc9cbead9b3c5ae41","*   The Board of Directors has approved the allotment of 24,87,100 new equity shares by converting Compulsorily Convertible Preference Shares (CCPS).\n*   The entire allotment was made exclusively to 11 entities belonging to the \"Promoter & Promoter Group,\" strengthening their control.\n*   The conversion price was at face value (₹10 per share), which is a potential red flag for public shareholders due to equity dilution.\n*   Consequent to the allotment, the company's paid-up equity share capital increased to ₹19.67 crore.\n*   The Board also approved the re-appointment of M\u002Fs Sidharth K Agarwal & Co. as the Internal Auditor for the Financial Year 2026-27.",{"company_name":267,"filing_date":268,"filing_source":9,"headline":269,"id":270,"stock_code":224,"summary_text":271},"Muthoot Capital Services Ltd","2026-05-13T13:56:42.327000","FY26 Results: AUM Hits ₹3,441 Cr, Plans ₹400 Cr Fundraise Amid Strategic Overhaul","6a043643890e096a6fc5bf63","*   **AUM Growth:** Total Assets Under Management (AUM) grew to ₹3,441 Crores. The company's own loan book grew 29% to ₹2,758 Crores, offsetting a strategic exit from the co-lending business (down 37%).\n*   **New Growth Verticals:** The company is aggressively expanding into new segments. Commercial Vehicle (CV) AUM grew 292% and Used Car AUM grew 80% year-over-year.\n*   **Asset Quality Concern:** Gross NPA stood at a high 6.96%, significantly impacted by a single corporate loan default of ₹15.51 Crores. Management noted the retail GNPA is lower at 5.64%.\n*   **Profitability Pressure:** Heavy investments in technology and new verticals have resulted in a high cost-to-income ratio of 85%, impacting current profitability.\n*   **Major Fundraise Planned:** The company is in talks to raise ~₹400 Crores through equity to fund growth, targeting an AUM of over ₹4,000 Crores in FY27.\n*   **Shareholder Frustration:** Management addressed significant investor frustration over the lack of dividends for the past 8-10 years, citing the need to reinvest capital for its turnaround strategy.",{"company_name":273,"filing_date":274,"filing_source":9,"headline":275,"id":276,"stock_code":277,"summary_text":278},"Concord Control Systems Ltd","2026-05-13T13:56:41.973000","Posts Record-Breaking FY26 Results with 87% Profit Growth","6a043604f35e30561cffb74f","543619","*   \u003Cb>Record Performance (FY26):\u003C\u002Fb> The company reported its \"strongest year on record\" with Total Revenue growing 67% YoY to ₹213.73 Cr.\n*   \u003Cb>Profitability Surge:\u003C\u002Fb> Profit After Tax (PAT) jumped 87.2% YoY to ₹42.40 Cr, while EBITDA more than doubled, growing 103.4% YoY.\n*   \u003Cb>Strong Outlook:\u003C\u002Fb> Reports a robust order book of ₹696.99 Crore as of March 31, 2026, providing strong forward revenue visibility.\n*   \u003Cb>Corporate Actions:\u003C\u002Fb> Completed the amalgamation of Advanced Rail Controls Pvt. Ltd. and issued bonus shares to shareholders in a 3:5 ratio.\n*   \u003Cb>Important Note:\u003C\u002Fb> Due to the amalgamation, the company states that FY26 financial figures are not comparable with previously published results.",{"company_name":130,"filing_date":280,"filing_source":9,"headline":281,"id":282,"stock_code":62,"summary_text":283},"2026-05-13T13:56:41.971000","FY26 Results: Losses Widen on R&D Push as Key Drug Trials Advance","6a0436265236ec99893a1bec","• \u003Cb>Financials:\u003C\u002Fb> Net loss for FY26 widened by 72% to ₹276.3 Cr, driven by a 72.4% surge in R&D expenses to ₹248.2 Cr as the company ramps up clinical activities.\n• \u003Cb>Capital Position:\u003C\u002Fb> The company has a strong cash runway, with ₹503.6 Cr in unutilised funds from a recent preferential warrant issue, which is funding the increased R&D spend.\n• \u003Cb>Pipeline Update (Phase 3):\u003C\u002Fb> The global Phase 3 trial for SUVN-502 (Alzheimer's agitation) has reached 76% enrollment. A new global Phase 3 study for SUVN-G3031 (Narcolepsy) has been initiated.\n• \u003Cb>Other Key Trials:\u003C\u002Fb> The Phase 2B study for SUVN-911 is complete with data expected soon, and a new Phase 2 study for SUVN-D4010 (Depression) is set to begin in 2026.\n• \u003Cb>Governance & Audit:\u003C\u002Fb> Auditors issued a clean (unmodified) opinion. The Board noted a past SEBI compliance issue for which BSE has waived a fine, and advised management to ensure stricter compliance going forward.",{"company_name":285,"filing_date":286,"filing_source":9,"headline":287,"id":288,"stock_code":289,"summary_text":290},"Borosil Renewables Ltd","2026-05-13T13:56:41.754000","Publishes Audited FY26 Results with Clean Audit Opinion","6a04360cf43b112c8d923679","BORORENEW","*   The Board has approved the Audited Financial Results for the quarter and financial year ended March 31, 2026.\n*   The company's Statutory Auditors have issued a clean audit report with an \"unmodified opinion,\" a positive signal for investors.\n*   In compliance with regulations, the results have been published in Business Standard (English) and NavShakti (Marathi) newspapers.\n*   Detailed financial statements and the auditor's report are now available on the company's website and the stock exchange portals (BSE & NSE).",{"company_name":292,"filing_date":293,"filing_source":9,"headline":294,"id":295,"stock_code":296,"summary_text":297},"Saregama India Ltd","2026-05-13T13:56:41.700000","Shareholders Alert: Claim Dividends to Avoid Share Transfer","6a0435faec7f5de862c5983b","SAREGAMA","*   The company is transferring shares to the Investor Education and Protection Fund (IEPF) for which dividends have remained unclaimed for seven consecutive years.\n*   This action is triggered by unclaimed dividends from the Financial Year 2018-19.\n*   **CRITICAL DEADLINE:** Affected shareholders must claim their unpaid dividends by **Tuesday, 11th August, 2026**, to prevent their shares from being transferred.\n*   Shares for which claims are not received by the deadline will be transferred to the IEPF on **Monday, 17th August, 2026**.\n*   A list of affected shareholders is available on the company's website.",{"company_name":160,"filing_date":299,"filing_source":52,"headline":300,"id":301,"stock_code":75,"summary_text":302},"2026-05-13T13:56:41.137000","Declares ₹7.00 Dividend; FY26 Profit Impacted by One-Off Charge","6a04362fecaa861d94924cff","*   The Board has recommended a final dividend of **₹7.00 per equity share** (350%) for the financial year 2025-26.\n*   Consolidated Profit After Tax (PAT) fell by 9.9% YoY to **₹3,772 Million**, primarily due to a one-off exceptional charge of ₹417 Million related to new Labour Codes.\n*   Revenue from operations grew by 1.02% to **₹45,380 Million**, driven entirely by international business growth (+7.26%) as domestic revenue declined slightly (-2.44%).\n*   Basic Earnings Per Share (EPS) for the year stood at **₹47.05**, a 10% decrease from the previous year's ₹52.29.\n*   A strategic merger of subsidiaries allowed the company to utilize **₹1,261 Million in losses**, which significantly reduced the consolidated tax expense for the year.",{"company_name":304,"filing_date":305,"filing_source":52,"headline":306,"id":307,"stock_code":289,"summary_text":308},"BOROSIL RENEWABLES LIMITED","2026-05-13T13:56:40.830000","Publishes Audited FY26 Results with Unmodified Opinion","6a0435f3bf8f716f13ffcfff","*   The company has published its audited financial results for the quarter and financial year ended March 31, 2026.\n*   Statutory Auditors have issued an **unmodified opinion**, indicating a clean report with no qualifications or adverse remarks on the financial statements.\n*   This filing is a regulatory intimation about the newspaper publication of the results, as required by SEBI.\n*   The results were published in 'Business Standard' (English) and 'NavShakti' (Marathi) on May 13, 2026.\n*   Full financial details are available on the company's and stock exchanges' websites.",{"company_name":310,"filing_date":311,"filing_source":52,"headline":312,"id":313,"stock_code":296,"summary_text":314},"Saregama India Limited","2026-05-13T13:56:40.766000","Final Call for Unclaimed Dividends","6a0435efc9cbead9b3c5ae3f","*   The company has issued a notice regarding the mandatory transfer of shares to the Investor Education and Protection Fund (IEPF).\n*   This affects shareholders who have not claimed dividends for seven consecutive years, starting with the Final Dividend for FY 2018-19.\n*   To prevent the transfer of your shares, you must claim your unpaid dividends by **Tuesday, August 11, 2026**.\n*   Shares corresponding to unclaimed dividends will be transferred to the IEPF on **Monday, August 17, 2026**.\n*   Shareholders can contact the company or its RTA (MUFG Intime India) to claim dividends before the deadline.",{"company_name":160,"filing_date":316,"filing_source":52,"headline":317,"id":318,"stock_code":75,"summary_text":319},"2026-05-13T13:56:40.589000","FY26 Results: Profit Dips on One-Time Charge, Declares ₹7 Dividend","6a04360a0c6b4fb98a925d23","• **FY26 Performance:** Revenue grew 1.02% to ₹45,380 Mn, while Net Profit After Tax (PAT) declined 10.46% to ₹3,612 Mn year-on-year.\n• **Dividend Declared:** The Board recommended a final dividend of ₹7.00 per equity share (350%). The record date is set for July 24, 2026.\n• **Exceptional Item:** Profitability was significantly impacted by a one-time exceptional charge of ₹417 Million due to the implementation of new Labour Codes.\n• **Tax Benefit:** The company utilized tax losses of ₹1,261 Million following a subsidiary merger, which positively impacted the total tax expense for the year.\n• **Auditor's Opinion:** Statutory Auditors issued an unmodified (clean) opinion on the annual financial results.",{"company_name":58,"filing_date":321,"filing_source":52,"headline":322,"id":323,"stock_code":62,"summary_text":324},"2026-05-13T13:56:40.484000","FY26 Results: R&D Spend Surges & Losses Widen as Clinical Trials Advance","6a043618a157653c663a4049","*   **Financials:** Net Loss for FY26 widened by 71.9% to ₹(27,634.41) Lakhs, driven by a 72.4% surge in R&D expenses as the company accelerated clinical activities.\n*   **Clinical Pipeline:** Significant progress was made, with the Global Phase 3 trial for SUVN-502 (Masupirdine) reaching 76% enrollment and a new Global Phase 3 study initiated for SUVN-G3031 (Samelisant).\n*   **Cash & Funding:** Negative cash flow from operations nearly doubled to ₹(30,178.67) Lakhs, highlighting a high cash burn. The company has a balance of ₹50,363.89 Lakhs from a recent preferential issue to fund these activities.\n*   **Compliance Red Flag:** The Board noted penalties for a past compliance lapse. While BSE has waived its fine, the outcome of the waiver application with NSE is still pending.",{"company_name":326,"filing_date":327,"filing_source":52,"headline":328,"id":329,"stock_code":40,"summary_text":330},"Blue Coast Hotels Limited","2026-05-13T13:56:40.453000","Board Approves Share Allotment to Promoter Group, Re-appoints Auditor","6a0435f5abd16353d2ffdf18","*   The Board approved the allotment of 2,487,100 new equity shares exclusively to the Promoter and Promoter Group.\n*   This allotment was made by converting Compulsorily Convertible Preference Shares (CCPS) at a ratio of 10 equity shares for every 1 CCPS.\n*   The action increases the promoter group's shareholding and results in equity dilution for public shareholders.\n*   M\u002Fs Sidharth K Agarwal & Co., Chartered Accountants, were re-appointed as the company's Internal Auditor for the financial year 2026-27.",{"company_name":332,"filing_date":333,"filing_source":52,"headline":334,"id":335,"stock_code":336,"summary_text":337},"Deepak Nitrite Limited","2026-05-13T13:56:40.429000","Announces Q4 & FY26 Earnings Conference Call","6a0435e6890e096a6fc5bf61","DEEPAKNTR","*   The company will host its earnings conference call to discuss financial results for the fourth quarter and year ended March 31, 2026.\n*   The call is scheduled for **Monday, May 18, 2026, at 3:30 PM IST.**\n*   Senior management, including Mr. Maulik Mehta (Deputy MD) and Mr. Sanjay Upadhyay (Director - Finance & Group CFO), will be present.\n*   The filing provides dial-in details and a pre-registration link for stakeholders to join.",{"company_name":339,"filing_date":340,"filing_source":9,"headline":341,"id":342,"stock_code":231,"summary_text":343},"Jet Freight Logistics Ltd","2026-05-13T13:51:41.368000","FY26 Results: 81% Profit Jump Clouded by Negative Cash Flow","6a043509bf8f716f13ffcffa","*   \u003Cb>Profit After Tax (PAT)\u003C\u002Fb> surged by 81.5% to ₹680.86 Lakhs for FY26, largely due to a change in the company's tax regime.\n*   \u003Cb>Revenue from Operations\u003C\u002Fb> remained flat, showing minimal growth of 0.12% year-over-year.\n*   \u003Cb>🔴 Red Flag:\u003C\u002Fb> Cash Flow from Operations worsened significantly to a negative ₹(814.10) Lakhs, down from a negative ₹(252.00) Lakhs in the previous year, indicating profits are not converting to cash.\n*   The negative cash flow is primarily driven by a large increase in trade receivables, pointing to potential issues with cash collection.\n*   The Statutory Auditor provided an unmodified (clean) opinion on the financial statements.\n*   The company appointed M\u002Fs. Daya & Associates as its new Internal Auditor for FY 2026-27.",{"company_name":345,"filing_date":346,"filing_source":9,"headline":347,"id":348,"stock_code":157,"summary_text":349},"Onesource Specialty Pharma Ltd","2026-05-13T13:51:41.363000","Mixed FY26 Results: Strong Q4 Driven by GLP-1s, but Key Acquisition Paused","6a043510abd16353d2ffdf14","- **Weak Full-Year (FY26) Results:** While revenue was flat (-2%), EBITDA plunged 35% and Adjusted PAT fell 68% YoY, with margins contracting significantly.\n- **Strong Q4 Turnaround:** The company saw a sharp sequential recovery in Q4FY26, with revenue up 47% and EBITDA up over 5x, driven by the commercial launch of Semaglutide in India.\n- **Major Acquisition Paused:** The proposed acquisition of two specialty injectable assets from Steriscience has been put on hold due to valuation concerns. The board will not pursue the deal in its current form and will revisit it after FY28.\n- **FY28 Guidance Reaffirmed:** Despite the weak annual performance and paused deal, management reaffirmed its ambitious guidance of $400M in revenue and ~40% EBITDA margin by FY28.",{"company_name":351,"filing_date":352,"filing_source":9,"headline":353,"id":354,"stock_code":355,"summary_text":356},"IIFL Capital Services Ltd","2026-05-13T13:51:41.177000","Fairfax Group to Invest ~₹2,000 Cr & Launch Open Offer for 51% Control","6a04352ea157653c663a4045","IIFLCAPS","*   Fairfax Group will make a strategic investment of approximately ₹2,000 Crores into the company via a preferential allotment at ₹350 per share.\n*   This triggers a mandatory open offer to acquire up to 26% of the company from public shareholders, also at a price of ₹350 per share.\n*   The transaction is structured for the Acquirer (Fairfax) to achieve a minimum 51% shareholding and become a new promoter.\n*   **Key Red Flag:** The company's net profit declined significantly in the most recent fiscal year (FY26), dropping from ₹713 Cr to ₹564 Cr.\n*   **Transaction Risk:** The deal's completion is uncertain as it is contingent on a large and complex number of regulatory approvals.",{"company_name":358,"filing_date":359,"filing_source":9,"headline":360,"id":361,"stock_code":362,"summary_text":363},"International Combustion India Ltd","2026-05-13T13:51:41.079000","Important Update: Change in Registrar & Share Transfer Agent (RTA)","6a0434c0ec7f5de862c5982a","505737","*   The company has appointed a new Registrar and Share Transfer Agent (RTA) following the merger of its previous RTA, CB Management Services Private Limited, with MUFG Intime India Private Limited.\n*   Effective May 8, 2026, **MUFG Intime India Private Limited** is the new official RTA for the company.\n*   All shareholders must now direct all future correspondence regarding share transfers, dividends, dematerialization, and other related services to the new RTA.\n*   New RTA Contact: MUFG Intime India Private Limited, Rasoi Court, 5th Floor, 20 R. N. Mukherjee Road, Kolkata – 700001. Email: investor.helpdesk@in.mpms.mufg.com.",{"company_name":365,"filing_date":366,"filing_source":9,"headline":367,"id":368,"stock_code":369,"summary_text":370},"Anlon Healthcare Ltd","2026-05-13T13:51:41.038000","IPO Fund Update: Anlon Shifts Strategy, Acquires Two Companies","6a0434d75236ec99893a1be2","544497","*   As of March 31, 2026, the company has utilized ₹12,089.80 lakh of its ₹12,103.00 lakh IPO proceeds, with only ₹13.20 lakh remaining unutilized.\n*   The company has materially changed its post-IPO strategy, shifting the use of funds from organic expansion to include \"inorganic growth\" (acquisitions), a move approved by shareholders in January 2026.\n*   In line with this new strategy, Anlon acquired two companies using IPO proceeds: Bizotic Life Science Private Limited (for ₹379.69 lakh) and Apiqo Organics Private Limited (for ₹540.06 lakh).\n*   The monitoring agency (CRISIL) reported this as a \"deviation\" from the original IPO plan but noted it was compliant due to the subsequent shareholder approval.",{"company_name":372,"filing_date":373,"filing_source":9,"headline":374,"id":375,"stock_code":376,"summary_text":377},"Hindalco Industries Ltd","2026-05-13T13:51:40.687000","Shareholder Alert: Claim Unpaid Dividends & Update KYC","6a0434daf43b112c8d923670","HINDALCO","- The company is participating in the \"Saksham Niveshak\" shareholder awareness campaign, running from April 1, 2026, to July 9, 2026.\n- Shareholders are urged to claim any unpaid\u002Funclaimed dividends and update their KYC details (Bank Mandates, Nominee, etc.).\n- This action is crucial to prevent the transfer of shares and dividends to the government's Investor Education and Protection Fund (IEPF).\n- This filing is a positive governance step for shareholder engagement; no other material financial or operational updates were disclosed.",{"company_name":71,"filing_date":379,"filing_source":9,"headline":380,"id":381,"stock_code":75,"summary_text":382},"2026-05-13T13:51:40.606000","Declares ₹7 Dividend; FY26 Profits Hit by One-Off Charges","6a0434fdf35e30561cffb749","*   The Board has recommended a final dividend of **₹7.00 per share** (350%) for the financial year 2025-26.\n*   **Consolidated Performance (YoY):** Revenue grew 1% to ₹45,380 Mn, but Profit After Tax (PAT) declined 10.5% to ₹3,612 Mn.\n*   **Profitability Impact:** The decline in profit was primarily due to a one-off exceptional charge of **₹389 Mn** related to the implementation of new Labour Codes.\n*   **Key Adjustments:** Results were also influenced by a significant tax benefit of **₹1,261 Mn** from a subsidiary merger and a **₹564 Mn** provision write-back at the standalone level.\n*   **Earnings Per Share (EPS):** Consolidated Basic EPS for the year stood at **₹47.05**, a decrease from ₹52.29 in the previous year.",{"company_name":384,"filing_date":385,"filing_source":9,"headline":386,"id":387,"stock_code":388,"summary_text":389},"TVS Motor Company Ltd","2026-05-13T13:51:40.594000","Board Approves New Independent Director Appointment","6a0434c3c9cbead9b3c5ae33","TVSMOTOR","*   The Board of Directors has approved the appointment of \u003Cb>Mr. Ravindran Shanmugam\u003C\u002Fb> as a Non-Executive Independent Director.\n*   The appointment is for a five-year term, effective from 13th May 2026.\n*   This appointment is subject to shareholder approval, which will be sought via a Postal Ballot.",{"company_name":146,"filing_date":391,"filing_source":52,"headline":392,"id":393,"stock_code":150,"summary_text":394},"2026-05-13T13:51:40.122000","Announces Major Expansion into Gurugram with New Hospital Acquisition","6a0434ca58d87443453a3097","*   The Board has approved the acquisition of hospital assets (land and a building under construction) in Gurugram, Haryana for a cash consideration of ₹100 Crores.\n*   This acquisition marks the company's strategic entry into the Gurugram market to expand its presence in the Delhi NCR.\n*   The new facility has the potential to be developed into a hospital with a capacity of approximately 250 beds.\n*   An additional capex of ₹100 Crores is planned for medical equipment and completion, bringing the total project outlay to approximately ₹200 Crores.",{"company_name":396,"filing_date":397,"filing_source":52,"headline":398,"id":399,"stock_code":400,"summary_text":401},"Power Finance Corporation Limited","2026-05-13T13:51:40.025000","FY26 Profit Soars 10%, Final Dividend of ₹3.95\u002FShare Declared","6a0434e6ecaa861d94924cfa","PFC","*   \u003Cb>Strong FY26 Performance:\u003C\u002Fb> Consolidated Profit After Tax (PAT) grew by 10.19% YoY to ₹33,625 crore.\n*   \u003Cb>Shareholder Payout:\u003C\u002Fb> The Board recommended a final dividend of ₹3.95 per share. The total dividend for FY26 stands at ₹18.55 per share.\n*   \u003Cb>Improved Asset Quality:\u003C\u002Fb> A significant reduction in bad loans was reported, with the consolidated Gross Credit Impaired Assets ratio improving to just 0.66%.\n*   \u003Cb>Robust Capital Position:\u003C\u002Fb> The Capital Adequacy Ratio (CRAR) remains strong at 23.44%, well above regulatory requirements.\n*   \u003Cb>Governance Concern:\u003C\u002Fb> A potential red flag was noted as the Audit Committee is currently operating with only one Independent Director, pending further government appointments.",{"company_name":153,"filing_date":403,"filing_source":52,"headline":404,"id":405,"stock_code":157,"summary_text":406},"2026-05-13T13:51:39.948000","Allots 3,150 New Shares to Employees Under ESOP","6a0434bebf8f716f13ffcff8","*   The company has allotted **3,150 Equity Shares** to employees under its Employee Stock Option Plan (ESOP) on **13 May 2026**.\n*   This action increases the total number of outstanding shares to **114,645,801**.\n*   The allotment results in a minor equity dilution of approximately **0.0027%** for existing shareholders.\n*   The filing is a routine compliance update under SEBI's employee benefit regulations.",{"company_name":227,"filing_date":408,"filing_source":52,"headline":409,"id":410,"stock_code":231,"summary_text":411},"2026-05-13T13:51:39.875000","FY26 Results: Profit Soars 84% Despite Flat Revenue","6a0434d0890e096a6fc5bf57","*   \u003Cb>Profit Surge:\u003C\u002Fb> Consolidated Profit After Tax (PAT) jumped 84.4% year-over-year to ₹688.29 Lakhs for the fiscal year ending March 31, 2026.\n*   \u003Cb>Stagnant Revenue:\u003C\u002Fb> Revenue from operations remained flat, increasing by only 0.12% compared to the previous year.\n*   \u003Cb>EPS Growth:\u003C\u002Fb> Basic Earnings Per Share (EPS) increased significantly by 83.75% to ₹1.47.\n*   \u003Cb>New Internal Auditor:\u003C\u002Fb> The Board appointed M\u002Fs. Daya & Associates as the new Internal Auditors for the financial year 2026-27.\n*   \u003Cb>Clean Audit Report:\u003C\u002Fb> Statutory auditors issued an unmodified (clean) opinion on the annual financial statements.",{"company_name":413,"filing_date":414,"filing_source":52,"headline":415,"id":416,"stock_code":417,"summary_text":418},"The Ugar Sugar Works Limited","2026-05-13T13:51:39.757000","Auditors Issue Unmodified Opinion for FY26","6a0434b5a157653c663a4043","UGARSUGAR","*   The company has declared that its Statutory Auditor, Kirtane & Pandit LLP, has issued an Audit Report with an **unmodified opinion** for the financial year ended March 31, 2026.\n*   An unmodified opinion is a clean report, indicating that the financial statements are presented fairly and are free from material misstatement.\n*   This provides a higher degree of assurance to shareholders and investors regarding the reliability and accuracy of the company's financial results, enhancing investor confidence.",{"company_name":420,"filing_date":421,"filing_source":52,"headline":422,"id":423,"stock_code":376,"summary_text":424},"Hindalco Industries Limited","2026-05-13T13:51:39.660000","Shareholder Alert: Claim Your Unpaid Dividends & Update Your Details!","6a0434cc0c6b4fb98a925d0e","• Hindalco has published a notice for shareholders as part of the Investor Education and Protection Fund Authority (IEPFA) campaign.\n• The initiative urges shareholders to claim unpaid dividends and update their KYC, bank, and nominee details.\n• This is to prevent the transfer of shares and dividends to the government's IEPF account.\n• The campaign period is from April 1, 2026, to July 9, 2026.\n• Shareholders are advised to contact the company's RTA, MUFG Intime India Private Limited, for any assistance.",{"company_name":426,"filing_date":427,"filing_source":52,"headline":428,"id":429,"stock_code":388,"summary_text":430},"TVS Motor Company Limited","2026-05-13T13:51:39.574000","Board Proposes New Independent Director","6a0434bcabd16353d2ffdf11","*   The Board of Directors has approved the proposal to appoint Mr. Ravindran Shanmugam as a Non-Executive Independent Director.\n*   The appointment is for a five-year term, effective May 13, 2026, subject to shareholder approval.\n*   Shareholder consent for the appointment will be sought through a Postal Ballot.",{"company_name":432,"filing_date":433,"filing_source":9,"headline":434,"id":435,"stock_code":400,"summary_text":436},"Power Finance Corporation Ltd","2026-05-13T13:46:41.378000","Reports Strong FY26 Profit Growth, Announces ₹18.55 Total Dividend","6a0433deecaa861d94924cf5","*   **Strong Profit Growth (FY26):** Standalone Profit After Tax (PAT) grew by 15.55% to ₹20,051.34 Crores. Consolidated PAT rose 10.20% to ₹33,625.34 Crores.\n*   **High Dividend Payout:** The Board recommended a final dividend of ₹3.95 per share. The total dividend for FY26 stands at ₹18.55 per share.\n*   **Improved Asset Quality:** The company saw a significant reduction in bad loans. Consolidated Credit Impaired Assets (Stage 3) decreased from ₹18,169.50 Cr to ₹7,707.33 Cr.\n*   **Strong Capital Position:** The Capital to Risk (Weighted) Assets Ratio (CRAR) on a standalone basis is strong at 23.44%.\n*   **Governance Red Flag:** The Audit Committee's composition is not compliant, with only one Independent Director, which is a significant governance concern.",{"company_name":345,"filing_date":438,"filing_source":9,"headline":439,"id":440,"stock_code":157,"summary_text":441},"2026-05-13T13:46:41.334000","GLP-1 Success Drives Q4 Turnaround; Steriscience Deal Paused","6a0433eff35e30561cffb745","*   **FY26 Profitability Slump:** Full-year EBITDA declined 35% to ₹3,042M and Adjusted PAT fell 68% to ₹739M, despite a marginal 2% drop in revenue.\n*   **Strong Q4 Turnaround:** Driven by successful semaglutide (GLP-1) launches, Q4 EBITDA grew over 5x sequentially, signaling a strong operational recovery.\n*   **Acquisition Paused:** The significant acquisition of assets from Steriscience has been put on hold after stakeholders raised concerns about the valuation.\n*   **FY28 Guidance Reaffirmed:** Management reiterated its long-term target of achieving ~$400M in revenue with a steady-state EBITDA margin of ~40%.\n*   **Regulatory Excellence:** The company maintained a perfect GMP inspection record with 49 successful audits and secured key approvals from USFDA, EU, and ANVISA (Brazil).",{"company_name":443,"filing_date":444,"filing_source":9,"headline":445,"id":446,"stock_code":447,"summary_text":448},"Suryoday Small Finance Bank Ltd","2026-05-13T13:46:41.332000","Targets Doubling Profit in FY27 Amid Strategic Overhaul","6a0433a7ec7f5de862c59824","SURYODAY","*   **Profit Guidance:** Management guides to double Profit After Tax (PAT) in FY27 to over ₹300 Crores, after reporting a 32.2% YoY PAT growth to ₹152 Crores in FY26.\n*   **Asset Quality Plan:** Aims to reduce Gross NPA from 6.5% to a target of ~3% in FY27, critically dependent on claiming ₹450-₹550 Crores from the CGFMU guarantee scheme.\n*   **Growth & Deposits:** Reported strong 32.3% YoY growth in Total Deposits for FY26 and is targeting 20-30% asset growth for FY27.\n*   **Capital Strategy:** Plans to raise Tier 2 capital first to support growth, explicitly deferring an equity raise to avoid shareholder dilution until valuation improves.\n*   **Key Challenge:** Cost-to-Income ratio remains high at 73%. Management is targeting a reduction to 67-68% in FY27.",{"company_name":450,"filing_date":451,"filing_source":9,"headline":452,"id":453,"stock_code":454,"summary_text":455},"Swashthik Plascon Ltd","2026-05-13T13:46:41.226000","Board Meeting Scheduled to Approve Annual Financial Results","6a04338bf35e30561cffb743","544035","*   A meeting of the Board of Directors is scheduled for Saturday, May 23, 2026.\n*   The primary agenda is to consider and approve the audited financial results for the financial year ended March 31, 2026.\n*   The Trading Window for insiders has been closed since April 01, 2026, and will reopen 48 hours after the financial results are announced.",{"company_name":457,"filing_date":458,"filing_source":9,"headline":459,"id":460,"stock_code":461,"summary_text":462},"Saurashtra Cement Ltd","2026-05-13T13:46:40.982000","Announces Q4 & FY26 Financial Results Publication","6a0433b7f43b112c8d92366c","SAURASHCEM","*   The company has published newspaper advertisements announcing its audited financial results for the quarter and financial year ended March 31, 2026.\n*   This filing is a procedural notice; it does not contain specific financial figures like revenue or profit.\n*   The Board of Directors approved the results in a meeting held on May 12, 2026.\n*   The complete financial statements are available for stakeholders on the company's website and on the BSE\u002FNSE websites.",{"company_name":464,"filing_date":465,"filing_source":9,"headline":466,"id":467,"stock_code":336,"summary_text":468},"Deepak Nitrite Ltd","2026-05-13T13:46:40.903000","🗓️ Mark Your Calendars: Q4 & FY26 Earnings Call Announced!","6a0433925236ec99893a1bd9","*   Deepak Nitrite has scheduled its Earnings Conference Call to discuss financial results for the fourth quarter and financial year ended March 31, 2026.\n*   The call will take place on **Monday, May 18, 2026, at 3:30 PM IST**.\n*   Senior management, including Mr. Maulik Mehta (Deputy MD) and Mr. Sanjay Upadhyay (Director - Finance & Group CFO), will be present.\n*   The filing provides dial-in numbers and a pre-registration link for investors and analysts to join the call, which is hosted by IIFL Capital.",{"company_name":214,"filing_date":470,"filing_source":9,"headline":471,"id":472,"stock_code":150,"summary_text":473},"2026-05-13T13:46:40.866000","[Expands into Gurugram with ₹200 Crore Hospital Project]","6a04339dc9cbead9b3c5ae26","- The Board has approved the acquisition of a hospital asset (land and building under construction) in Gurugram for a cash consideration of ₹100 Crores.\n- An additional ₹100 Crores is planned for capital expenditure on medical equipment, bringing the total project outlay to approximately ₹200 Crores.\n- This strategic acquisition aims to expand the company's presence in the Delhi NCR market.\n- The new facility has a potential capacity of approximately 250 beds.\n- The transaction is expected to be completed within 45 days.",{"company_name":214,"filing_date":475,"filing_source":9,"headline":476,"id":477,"stock_code":150,"summary_text":478},"2026-05-13T13:46:40.842000","To Acquire New Hospital Asset in Gurugram for ₹100 Crore","6a04339cbf8f716f13ffcfdd","*   The Board has approved the acquisition of a hospital asset (land and building under construction) in Gurugram for a cash consideration of ₹100 Crores.\n*   This strategic move marks the company's entry into the Gurugram market and will add a potential capacity of approximately 250 beds to expand its presence in the Delhi NCR region.\n*   **Key Ambiguity:** The filing mentions an \"additional capex including medical equipment of Rs. 100 Crores,\" creating uncertainty whether the total project cost is ₹100 Crore or ₹200 Crore.",{"company_name":426,"filing_date":480,"filing_source":52,"headline":481,"id":482,"stock_code":388,"summary_text":483},"2026-05-13T13:46:40.298000","Files Blank Security Cover Certificate for March 2026 Quarter","6a043393ecaa861d94924cf1","*   The company filed its mandatory Security Cover Certificate for the quarter ended March 31, 2026, as required by SEBI regulations.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The submitted certificate is a blank template and does not contain any of the required financial data to assess the asset security for its listed debt.\n*   This incomplete filing fails to provide the necessary assurance to creditors and stakeholders regarding the adequacy of the company's asset cover.",{"company_name":485,"filing_date":486,"filing_source":52,"headline":487,"id":488,"stock_code":369,"summary_text":489},"Anlon Healthcare Limited","2026-05-13T13:46:40.285000","IPO Funds Almost Fully Utilized on Acquisitions & Expansion","6a0433b158d87443453a3090","*   Nearly all IPO proceeds have been utilized, with ₹12,089.80 lakhs spent out of the total ₹12,103.00 lakhs raised, leaving a balance of just ₹13.20 lakhs.\n*   The company officially changed its strategy to include \"inorganic growth\" (acquisitions), a move that was approved by shareholders via postal ballot.\n*   Following the new strategy, the company completed two acquisitions: Bizotic Life Science (for ₹379.69 lakhs) and Apiqo Organics (for ₹540.06 lakhs).\n*   Savings of ₹84.39 lakhs from lower-than-expected IPO expenses were reallocated by the board to \"General Corporate Purposes\".",{"company_name":396,"filing_date":491,"filing_source":52,"headline":492,"id":493,"stock_code":400,"summary_text":494},"2026-05-13T13:46:40.113000","FY26 Results: PAT Jumps 15.5%, Total Dividend Hits ₹18.55\u002FShare","6a0433bf890e096a6fc5bf4f","*   \u003Cb>Strong Profit Growth:\u003C\u002Fb> Standalone Profit After Tax (PAT) for FY26 grew by 15.55% to ₹20,051 Cr. Consolidated PAT grew 10.19% to ₹33,625 Cr.\n*   \u003Cb>Bumper Dividend:\u003C\u002Fb> The Board recommended a final dividend of ₹3.95 per share. The total dividend for FY26 stands at a substantial ₹18.55 per share.\n*   \u003Cb>Improved Asset Quality:\u003C\u002Fb> Asset quality improved dramatically, with the standalone Gross Credit Impaired Assets Ratio falling to just 1.09%.\n*   \u003Cb>Key Profit Driver:\u003C\u002Fb> A significant portion of the profit growth was driven by a one-time net reversal of impairment provisions of ₹1,816 Cr, which may not be recurring.\n*   \u003Cb>Governance Red Flag:\u003C\u002Fb> A material risk was noted as the company's Audit Committee is not compliant with regulatory requirements, having only one member instead of the mandated three.\n*   \u003Cb>Robust Capital:\u003C\u002Fb> The Capital Adequacy Ratio (CRAR) remains very strong at 23.44%, indicating a solid capital buffer.",{"company_name":396,"filing_date":496,"filing_source":52,"headline":497,"id":498,"stock_code":400,"summary_text":499},"2026-05-13T13:46:40.032000","FY26 Profits Surge, Total Dividend Hits ₹18.55\u002FShare","6a0433bcabd16353d2ffdf0c","*   Consolidated Profit After Tax (PAT) for FY26 grew 10.2% YoY to ₹33,625 Cr, driven by strong income and a significant reversal of provisions.\n*   The Board recommended a final dividend of ₹3.95 per share. This brings the total dividend for FY26 to ₹18.55 per share.\n*   Asset quality saw major improvement, with the Consolidated Gross Credit Impaired Assets ratio falling to an exceptionally low 0.66%.\n*   Capital Adequacy Ratio (CRAR) remains very strong at 23.44%, indicating a robust capital buffer.\n*   Governance Red Flag: The filing disclosed that the Audit Committee currently has only one Independent Director, which is a significant governance concern.",{"company_name":396,"filing_date":501,"filing_source":52,"headline":502,"id":503,"stock_code":400,"summary_text":504},"2026-05-13T13:46:39.989000","FY26 Results: PAT Jumps 15.5%, Final Dividend of ₹3.95 Declared","6a0433aa0c6b4fb98a925d05","*   \u003Cb>Strong Financials:\u003C\u002Fb> Standalone Profit After Tax (PAT) for FY26 grew by 15.55% to ₹20,051 crore, with Basic EPS at ₹60.76.\n*   \u003Cb>Final Dividend:\u003C\u002Fb> The Board recommended a final dividend of ₹3.95 per share. The total dividend for FY26 stands at ₹18.55 per share.\n*   \u003Cb>Improved Asset Quality:\u003C\u002Fb> Asset quality remains healthy, with the Standalone Gross Credit Impaired Assets ratio at 1.09% and Net at 0.15%.\n*   \u003Cb>Clean Audit Report:\u003C\u002Fb> Statutory Auditors issued an unmodified (\"clean\") opinion on the annual financial results.\n*   \u003Cb>Governance Red Flag:\u003C\u002Fb> The Audit Committee's composition is not compliant with regulatory norms, as it currently has only one Independent Director.",{"company_name":396,"filing_date":506,"filing_source":52,"headline":507,"id":508,"stock_code":400,"summary_text":509},"2026-05-13T13:46:39.954000","FY26 Results: Profit Jumps 16%, Declares ₹3.95 Final Dividend","6a0433caa157653c663a403c","*   \u003Cb>Stellar Profit Growth:\u003C\u002Fb> Standalone Profit After Tax (PAT) for FY26 surged by 15.55% to ₹20,051 Crores, driven by a significant reversal of provisions on financial instruments.\n*   \u003Cb>Shareholder Payout:\u003C\u002Fb> The Board recommended a final dividend of ₹3.95 per share. This brings the total dividend for the financial year to ₹18.55 per share.\n*   \u003Cb>Improved Asset Quality:\u003C\u002Fb> The company's risk profile improved significantly, with the consolidated Gross Credit Impaired Assets Ratio falling to just 0.66% and the Net Ratio at 0.13%.\n*   \u003Cb>Governance Red Flag:\u003C\u002Fb> The company disclosed that its Audit Committee composition is not compliant with statutory requirements, as it is awaiting the appointment of more independent directors by the government.",{"company_name":511,"filing_date":512,"filing_source":52,"headline":513,"id":514,"stock_code":515,"summary_text":516},"Stove Kraft Limited","2026-05-13T13:41:45.134000","FY26 Results: Profit Declines, Board Proposes NIL Dividend","6a04329bc9cbead9b3c5ae21","STOVEKRAFT","• Net Profit for FY26 fell by 7.32% to ₹2,976.78 lakhs from ₹3,211.75 lakhs in the previous year.\n• Total Income from Operations remained flat, growing just 0.45% YoY to ₹118,521.25 lakhs.\n• The Board has proposed a NIL dividend for the financial year ended 31 March 2026, a significant change for shareholders.\n• Basic EPS for the full year decreased to ₹9.06 from ₹9.77 in FY25.",{"company_name":518,"filing_date":519,"filing_source":9,"headline":520,"id":521,"stock_code":515,"summary_text":522},"Stove Kraft Ltd","2026-05-13T13:41:44.575000","Q4 Net Profit Jumps Over 32% Year-Over-Year","6a04328cf35e30561cffb73f","*   \u003Cb>Q4 FY26 Net Profit:\u003C\u002Fb> ₹15.25 crore, a \u003Cb>32.32% increase\u003C\u002Fb> year-over-year (YoY).\n*   \u003Cb>Q4 FY26 Revenue:\u003C\u002Fb> ₹364.50 crore, up \u003Cb>14.43%\u003C\u002Fb> YoY.\n*   \u003Cb>Full Year FY26 Net Profit:\u003C\u002Fb> ₹45.25 crore, a \u003Cb>16.80% increase\u003C\u002Fb> over the previous year.\n*   \u003Cb>Full Year FY26 EPS\u003C\u002Fb> grew to ₹13.71, up from ₹11.74 in FY25.",{"company_name":524,"filing_date":525,"filing_source":9,"headline":526,"id":527,"stock_code":528,"summary_text":529},"Platinum Industries Ltd","2026-05-13T13:41:42.257000","Reports FY26 Results & Guides for >40% Growth in FY27","6a04329558d87443453a308b","PLATIND","*   \u003Cb>FY26 Performance:\u003C\u002Fb> Consolidated Revenue grew 14.8% YoY to ₹4,504 mn, while EBITDA margin contracted by 130 bps. Q4 showed strong acceleration with revenue up 36.8% and PAT up 164.8% YoY.\n*   \u003Cb>Aggressive Guidance:\u003C\u002Fb> Management targets revenue growth exceeding 40% in FY27 and a 35% revenue CAGR from FY26-FY29, contingent on successful expansion.\n*   \u003Cb>Major Expansion:\u003C\u002Fb> Growth is expected to be driven by new capacity in Palghar, India (60,000 TPA) and a new greenfield project in Egypt (60,000 TPA) set to launch before Dec 2026.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The filing contains a significant error, stating in a document dated May 13, 2026, that a plant commenced operations on a future date (August 25, 2026), raising questions about the accuracy of the information presented.",{"company_name":432,"filing_date":531,"filing_source":9,"headline":532,"id":533,"stock_code":400,"summary_text":534},"2026-05-13T13:41:42.116000","Reports 16% PAT Growth for FY26, Recommends Final Dividend","6a04329cec7f5de862c59820","*   **Strong FY26 Performance:** Standalone Profit After Tax (PAT) grew 15.55% to ₹20,051 Cr, driven by higher revenue and a significant reversal of impairment provisions.\n*   **Shareholder Payout:** The Board recommended a final dividend of ₹3.95 per share. The total dividend for FY26 stands at ₹18.55 per share.\n*   **Improved Asset Quality:** Consolidated Gross Credit Impaired Assets Ratio improved to a strong 0.66%, with a robust Capital Adequacy Ratio of 23.44%.\n*   **Major Governance Red Flag:** The company disclosed its Audit Committee is non-compliant with regulations, having only one member instead of the mandated three, posing a significant governance risk.",{"company_name":536,"filing_date":537,"filing_source":9,"headline":538,"id":539,"stock_code":540,"summary_text":541},"Stallion India Fluorochemicals Ltd","2026-05-13T13:41:42.082000","FY26 Profit Jumps 36%, Raises ₹512 Cr+ for Expansion","6a04327f5236ec99893a1bd2","STALLION","*   **Strong FY26 Results:** Profit After Tax (PAT) surged by 35.6% to ₹4,384 Lakhs, with revenue from operations growing 14.1% to ₹43,068 Lakhs.\n*   **Major Capital Infusion:** The company raised approx. ₹512 Crores through an IPO (₹148.7 Cr) and a Rights Issue (₹363.9 Cr) during the financial year to fund expansion.\n*   **New Director Appointed:** The Board appointed Ms. Swati Ghosh as a new Non-Executive Independent Director, strengthening governance.\n*   **Key Concern:** The company over-utilized IPO funds for working capital by ₹770.53 Lakhs, a deviation from its prospectus that warrants investor attention.",{"company_name":543,"filing_date":544,"filing_source":9,"headline":545,"id":546,"stock_code":547,"summary_text":548},"Himadri Speciality Chemical Ltd","2026-05-13T13:41:41.942000","ESG Rating Upgraded by ICRA","6a043272f43b112c8d923665","HSCL","*   ICRA ESG Ratings Limited has upgraded the company's ESG rating, effective May 12, 2026.\n*   The combined ESG score has been revised upwards from 80 to **82**, remaining in the 'Exceptional' category.\n*   This is a material positive event that can enhance the company's appeal to institutional and ESG-focused investors.\n*   Management notes the upgrade is a \"testament to the strategic alignment of our operations with leading ESG benchmarks.\"",{"company_name":426,"filing_date":550,"filing_source":52,"headline":551,"id":552,"stock_code":388,"summary_text":553},"2026-05-13T13:41:40.228000","Confirms No Deviation in Use of NCRPS Proceeds","6a043274ecaa861d94924ce7","*   The company submitted a compliance filing for the quarter ended March 31, 2026, regarding the use of funds from its Non-Convertible Redeemable Preference Shares (NCRPS).\n*   TVS Motor has confirmed that there is **no material deviation** in the use of these proceeds compared to the objects for which they were issued.\n*   This disclosure provides assurance to investors and creditors that capital is being deployed for its stated purposes.\n*   Notably, the enclosed statement forms were marked \"Not Applicable,\" reinforcing the \"no deviation\" message but lacking specific quantitative data.",{"company_name":555,"filing_date":556,"filing_source":52,"headline":557,"id":558,"stock_code":559,"summary_text":560},"VA Tech Wabag Limited","2026-05-13T13:41:40.070000","New Shares Allotted Under ESOP Scheme","6a04326ac9cbead9b3c5ae1f","WABAG","*   Allotted 6,068 new equity shares to employees under the WABAG Centenary Stock Option Scheme 2023.\n*   The shares were issued at an exercise price of ₹ 513 per share.\n*   Following the allotment, the total number of issued equity shares has increased from 62,309,595 to 62,315,663.\n*   This action results in a minor equity dilution of approximately 0.01%.\n*   The new shares will be listed on BSE & NSE and will rank equally with existing shares.",{"company_name":244,"filing_date":562,"filing_source":52,"headline":563,"id":564,"stock_code":117,"summary_text":565},"2026-05-13T13:41:39.986000","FY26 Results: Revenue Up 15%, but Debt Soars & Cash Flow Turns Negative","6a043281bf8f716f13ffcfd8","*   Reports a 15.15% YoY increase in Revenue to ₹680.9 Cr and an 8.04% rise in Net Profit to ₹28.8 Cr for FY26.\n*   The Board has recommended a final dividend of **Re. 0.50 per share (5%)**.\n*   \u003Cb>RED FLAG:\u003C\u002Fb> Recorded a negative Cash Flow from Operations of ₹(41.4) Cr, a sharp reversal from a positive ₹35 Cr in the previous year, despite reporting a profit.\n*   \u003Cb>RED FLAG:\u003C\u002Fb> Funded a major capex cycle by significantly increasing debt, with short-term borrowings up 313% and long-term borrowings up 164%.\n*   Received an unmodified (clean) audit opinion from its statutory auditors.",{"company_name":567,"filing_date":568,"filing_source":52,"headline":569,"id":570,"stock_code":571,"summary_text":572},"Pritika Auto Industries Limited","2026-05-13T13:41:39.982000","Pritika Auto Cancels Land Deal Amid Litigation Concerns","6a04326ea157653c663a402f","PRITIKAUTO","• The company has reversed its decision to acquire a 64 Kanal property in Hoshiarpur, Punjab, which it had won in an e-auction.\n• The cancellation was prompted by the discovery of pending litigation related to the property, with the company stating it \"did not wish to involve itself in litigation.\"\n• Following the company's request, the High Court of Punjab & Haryana has set aside the auction and ordered a full refund of the money paid.\n• This represents a setback to the company's near-term expansion plans, though it preserves capital and avoids potential legal costs.\n• The late discovery of litigation raises questions about the initial due diligence, but the withdrawal is seen as a prudent risk-mitigating action.",{"company_name":153,"filing_date":574,"filing_source":52,"headline":575,"id":576,"stock_code":157,"summary_text":577},"2026-05-13T13:41:39.686000","Strong Q4 Recovery & FY28 Guidance Reaffirmed, but Major Acquisition Halted","6a0432930c6b4fb98a925cfe","*   \u003Cb>Financials:\u003C\u002Fb> Q4 FY26 showed a strong recovery with 47% QoQ revenue growth, driven by Semaglutide launches. However, full-year FY26 revenue declined 2% and EBITDA fell 35% YoY due to earlier delays and higher costs.\n*   \u003Cb>Guidance Reaffirmed:\u003C\u002Fb> The company explicitly reaffirmed its ambitious FY28 guidance of $400M in revenue with ~40% EBITDA margins, signaling confidence in its GLP-1 and Biologics pipeline.\n*   \u003Cb>Major Red Flag:\u003C\u002Fb> The proposed acquisition of two specialty injectable assets from Steriscience has been paused due to valuation concerns. The Board will not pursue the transaction in its current form.\n*   \u003Cb>Key Growth Driver:\u003C\u002Fb> The Drug-Device Combinations (DDC) segment, particularly GLP-1s, is the primary growth engine, securing the first generic Semaglutide approvals in G7 countries.",{"company_name":579,"filing_date":580,"filing_source":52,"headline":581,"id":582,"stock_code":461,"summary_text":583},"Saurashtra Cement Limited","2026-05-13T13:41:39.669000","Publishes Audited Financial Results for FY26","6a04326b890e096a6fc5bf3a","*   The company has published its Audited Financial Results for the quarter and financial year ended March 31, 2026.\n*   This is a regulatory disclosure informing that the results have been advertised in the 'Business Standard' (English) and 'Jai Hind' (Gujarati) newspapers.\n*   The filing itself does not contain financial data; investors are directed to the company's website or stock exchange portals for the full results.\n*   The Board of Directors approved the results in a meeting held on May 12, 2026.",{"company_name":585,"filing_date":586,"filing_source":52,"headline":587,"id":588,"stock_code":589,"summary_text":590},"Kamat Hotels (I) Limited","2026-05-13T13:41:39.628000","FY26 Net Profit Jumps Over 30%","6a043278abd16353d2ffdf00","KAMATHOTEL","*   Reports a 30.52% YoY increase in full-year Net Profit to ₹3,810.14 Lakhs for FY26.\n*   Q4 Net Profit saw a significant surge of 49.16% YoY, reaching ₹1,350.11 Lakhs.\n*   Total income for FY26 grew by 11.36% to ₹31,315.11 Lakhs.\n*   Annual Earnings Per Share (EPS) improved to ₹17.24, up from ₹13.21 in the previous year.",{"company_name":592,"filing_date":593,"filing_source":9,"headline":594,"id":595,"stock_code":596,"summary_text":597},"Kamat Hotels (India) Ltd","2026-05-13T13:36:41.138000","Reports Strong FY26 Results & Recommends Dividend","6a04317af43b112c8d92365f","KANANIIND","*   **FY26 Net Profit:** Grew by 41.46% YoY to ₹ 6,750.08 Lakhs.\n*   **Q4 FY26 Net Profit:** Surged by 70.85% YoY to ₹ 2,188.43 Lakhs.\n*   **FY26 Total Income:** Increased by 19.88% YoY to ₹ 38,011.53 Lakhs.\n*   **Dividend:** The Board has recommended a Final Dividend of ₹ 2 per equity share, subject to shareholder approval.\n*   **EPS:** Basic EPS for FY26 stood at ₹ 26.60, up from ₹ 18.80 in the previous year.",{"company_name":599,"filing_date":600,"filing_source":9,"headline":601,"id":602,"stock_code":603,"summary_text":604},"Rasi Electrodes Ltd","2026-05-13T13:36:41.109000","Board to Consider Sale of Surplus Land to Unlock Value","6a043167abd16353d2ffdefb","531233","*   A Board Meeting is scheduled for May 20, 2026, to discuss key corporate matters.\n*   The primary agenda is to consider the in-principle approval for the sale of surplus vacant land in Tiruvallur District, Tamilnadu, with the stated goal to \"unlock value.\"\n*   The Board will also consider approving a Postal Ballot to seek shareholder consent for the proposed asset sale.\n*   Additionally, the agenda includes authorizing the appointment of a Secretarial Auditor for various compliance and audit reports for FY26 and subsequent quarters.",{"company_name":384,"filing_date":606,"filing_source":9,"headline":607,"id":608,"stock_code":388,"summary_text":609},"2026-05-13T13:36:40.972000","Record Profits, Big Dividend, and a Unique Bonus Share Issue","6a04316f5236ec99893a1bcc","*   **Record Performance:** Reports highest-ever annual revenue of ₹47,270 Cr (up 30%) and Operating Profit Before Tax of ₹4,975 Cr (up 40%).\n*   **Strong Sales Growth:** Achieved record annual sales of 5.9 million units (up 24%), led by exceptional growth in Three-wheelers (+63%) and Electric Vehicles (+33%).\n*   **Significant Dividend:** Declared an interim dividend of **₹12 per share (1,200%)**, amounting to a ₹570 Crore payout to shareholders.\n*   **Unique Bonus Issue:** Issued 4 bonus Non-Convertible Redeemable Preference Shares (NCRPS) for every 1 equity share held. This represents a **₹1,900 Crore** value distribution, with the shares maturing on September 1, 2026.\n*   **Key Accounting Note:** Prior year Q4 results were 'normalized' to exclude a one-time Production Linked Incentive (PLI) benefit, making the 36% revenue growth a more accurate comparison.",{"company_name":611,"filing_date":612,"filing_source":9,"headline":613,"id":614,"stock_code":559,"summary_text":615},"VA Tech Wabag Ltd","2026-05-13T13:36:40.786000","Allots Equity Shares Under Employee Stock Option Plan","6a04313fec7f5de862c5980b","*   The Board has allotted **6,068 Equity Shares** to employees under the \"WABAG Centenary Stock Option Scheme 2023\".\n*   Shares were issued at an exercise price of **₹513 per share**, resulting in a total cash inflow of **₹31.13 Lakhs**.\n*   Following the allotment, the company's paid-up share capital has increased to **₹12,46,31,326**.\n*   The total number of outstanding equity shares is now **6,23,15,663**, resulting in a minor equity dilution of ~0.0097%.",{"company_name":617,"filing_date":618,"filing_source":52,"headline":619,"id":620,"stock_code":621,"summary_text":622},"Vaidya Sane Ayurved Laboratories Limited","2026-05-13T13:36:40.780000","Earnings Conference Call for H2 & FY26 Results Announced","6a043137f43b112c8d92365d","MADHAVBAUG","*   The company has scheduled an Earnings Conference Call to discuss its financial and operational performance for the second half (H2) and the full financial year 2026 (FY26).\n*   The call will take place on Monday, 18th May 2026, at 12:00 PM IST.\n*   Top management, including the Chairman & MD (Dr. Rohit Madhav Sane), will be present to address investors and analysts.\n*   This filing is a procedural intimation as per SEBI regulations; no financial results are disclosed in this document.",true,100,20,2410]